Q2 2025 Holdings
Filed 2025-08-14 | 17 holdings | $129.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $42.2M | 2,317,542 | 32.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $15.6M | 155,000 | 12.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $14.0M | 400,000 | 10.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $12.4M | 232,446 | 9.5% |
| ELI Lilly & CoPut | PUT | 532457958 | $11.7M | 15,000 | 9.0% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $5.0M | 3,256,501 | 3.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $4.2M | 1,800,556 | 3.2% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.0M | 110,000 | 3.1% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $3.8M | 930,000 | 3.0% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $3.6M | 572,576 | 2.8% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $3.4M | 189,350 | 2.6% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $2.6M | 1,500,000 | 2.0% |
| Ultragenyx Pharmaceutical inCall | CALL | 90400D908 | $2.5M | 67,600 | 1.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.5M | 35,000 | 1.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.5M | 35,000 | 1.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.2M | 80,000 | 0.9% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $840.8K | 75,000 | 0.6% |